跳至主要内容
临床试验/NCT01654354
NCT01654354已完成不适用

Comparison of NEOVIST 370 INJ.(Iopromide 768.86mg) With Ultravist 370 INJ.(Iopromide 768.86mg) in Abdominal CT

Seoul National University Hospital0 个研究点目标入组 104 人开始时间: 2012年7月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
104
主要终点
imaging quality

研究概览

简要总结

Comparison of NEOVIST 370 INJ.(Iopromide 768.86mg) with Ultravist 370 INJ.(Iopromide 768.86mg) in abdominal CT

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
20 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 20 to 75 years old.
  • Subjects who need CT scan
  • Subjects who are willing to participate in the study and to write the informed consent form.

排除标准

  • Subjects with severe hepatopathy whose AST or ALT ≥ 1,000 IU/L, Subjects with liver cirrhosis whose AST or ALT ≥ UNL(upper normal limit) X 3
  • Severe disorder of thyroid gland
  • homocystinuria
  • pregnant or breastfeeding female subjects, or female subjects with childbearing potential who are not willing to use proper contraception methods
  • Participation in another clinical trial within 30days of enrollment into this study.

结局指标

主要结局

imaging quality

时间窗: end of study enrollment

Two readers evaluate image quality of the abdomen CT by four-points scale

Adverse reaction

时间窗: immediate after CT scan

次要结局

  • SNR (signal to noise ratio) / CNR (contrast to noise ratio)(at the end or enrollment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jung-Eun Cheon

Associate Professor in Radiology(Pediatric Radiology)

Seoul National University Hospital

相似试验